NASDAQ:PLXSPlexus Stock Price, Forecast & News

Plexus' stock was trading at $60.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PLXS stock has increased by 11.1% and is now trading at $67.44. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Plexus.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Plexus.

Plexus will be holding an earnings conference call on Wednesday, July 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Plexus Corp. (NASDAQ:PLXS) announced its quarterly earnings data on Wednesday, April, 22nd. The technology company reported $0.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.56 by $0.05. The technology company had revenue of $767 million for the quarter, compared to analysts' expectations of $741.22 million. Plexus had a return on equity of 11.45% and a net margin of 3.27%. The company's quarterly revenue was down 2.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.79 earnings per share. View Plexus' earnings history.

Plexus issued an update on its third quarter earnings guidance on Wednesday, April, 22nd. The company provided EPS guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.67. The company issued revenue guidance of $790-830 million, compared to the consensus revenue estimate of $763.23 million.

5 Wall Street analysts have issued twelve-month price objectives for Plexus' stock. Their forecasts range from $67.00 to $83.00. On average, they anticipate Plexus' stock price to reach $75.00 in the next year. This suggests a possible upside of 11.2% from the stock's current price. View analysts' price targets for Plexus.

Headlines about PLXS stock have been trending negative recently, according to InfoTrie. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Plexus earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Plexus.

Plexus saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 754,200 shares, a drop of 32.1% from the June 15th total of 1,110,000 shares. Based on an average daily volume of 192,500 shares, the days-to-cover ratio is currently 3.9 days. Approximately 2.7% of the company's stock are short sold. View Plexus' Current Options Chain.

Some companies that are related to Plexus include Trimble (TRMB), IPG Photonics (IPGP), Jabil (JBL), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), KEMET (KEM), TTM Technologies (TTMI), Methode Electronics (MEI), Benchmark Electronics (BHE), CTS (CTS), Park Electrochemical (PKE), Neonode (NEON) and Key Tronic (KTCC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), QUALCOMM (QCOM), Twitter (TWTR) and ConocoPhillips (COP).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus' stock is owned by a variety of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.09%), Envestnet Asset Management Inc. (0.09%) and Diversified Trust Co (0.02%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View institutional ownership trends for Plexus.

PLXS stock was bought by a variety of institutional investors in the last quarter, including Diversified Trust Co, Envestnet Asset Management Inc., and State of Alaska Department of Revenue. View insider buying and selling activity for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $67.44.

Plexus has a market capitalization of $1.97 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.

The official website for Plexus is www.plexus.com.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]